Ectopic ACTH Secretion clinical trials at University of California Health
1 in progress, 0 open to eligible people
Showing trials for
SPI-62 as a Treatment for Adrenocorticotropic Hormone-dependent Cushing's Syndrome
Sorry, not currently recruiting here
This is a randomized, placebo-controlled, crossover study of SPI-62 in subjects with ACTH-dependent Cushing's syndrome. Subjects will receive each of the following 2 treatments for 12 weeks: SPI-62 and matching placebo
Our lead scientists for Ectopic ACTH Secretion research studies include Anthony Heaney, MD.